Showing results (1951-1960 of 1,980) with videos related to

Sort By:
Pageof 198
Leukemia|August 1, 2014
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemiaD J DeAngelo, K E Stevenson, S E Dahlberg, et al.
Science (New York, N.Y.)|August 27, 1993
Chemical loss of ozone in the arctic polar vortex in the winter of 1991-1992R J Salawitch, S C Wofsy, E W Gottlieb, et al.
Scientific Reports|November 7, 2022
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancerFabio Quaglia, Shiv Ram Krishn, Khalid Sossey-Alaoui, et al.
Gastrointestinal Endoscopy|March 22, 2008
Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter RegistryRobert A Ganz, Bergein F Overholt, Virender K Sharma, et al.
ACS ES&T Air|December 18, 2025
Characterization of German SF6 EmissionsKatharina Meixner, Thomas Wagenhäuser, Tanja J Schuck, et al.
Cancer Research Communications|July 30, 2024
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II TrialChanning J Paller, Marianna L Zahurak, Adel Mandl, et al.
BMC Public Health|December 9, 2017
A collaborative approach to adopting/adapting guidelines - The Australian 24-Hour Movement Guidelines for the early years (Birth to 5 years): an integration of physical activity, sedentary behavior, and sleepAnthony D Okely, Davina Ghersi, Kylie D Hesketh, et al.
Contemporary Clinical Trials|June 16, 2022
Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testingStacy Loeb, Heather H Cheng, Amy Leader, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 14, 2018
Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancerHuimin Lu, Nicholas Bowler, Larry A Harshyne, et al.
JCO Precision Oncology|September 19, 2025
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS RegistryStacy Loeb, Scott W Keith, Laura Gross, et al.
Pageof 198